🇺🇸 FDA
Patent

US 11058704

Inhibitors of adenosine 5′-nucleotidase

granted A61KA61K31/706A61K31/7064

Quick answer

US patent 11058704 (Inhibitors of adenosine 5′-nucleotidase) held by Arcus Biosciences, Inc. expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arcus Biosciences, Inc.
Grant date
Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/706, A61K31/7064, A61K31/7076, A61K39/3955